| Announce Date | 01/30/2026 |
| EPS Normalized Actual | $0.54 (Beat by $0.88) |
| EPS GAAP Actual | $0.54 (Beat by $0.88) |
| Revenue Actual | $1.56266B |
| Revenue Surprise | Beat by $1562.66M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.39189 |
| EPS GAAP Estimate | $-0.39189 |
| Revenue Estimate | $1.887693196B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 1 |
| Dec 2029 | 2.45 | 12.44 | 2.22876 | 2.7665 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.45 | 1.88118 | 1.56266B | 8.36% | -225.14M |
| FQ3 2025 (Sep 2025) | -0.23 | 0.17602 | 1.59116B | 7.61% | -204.79M |
| FQ2 2025 (Jun 2025) | -0.23 | 0.20739 | 1.692B | 14.02% | -93.26M |
| FQ1 2025 (Mar 2025) | -0.35 | -0.35 | 1.58B | 7.94% | 1580M |
| FQ4 2024 (Dec 2024) | -0.0596 | -0.0596 | 1.432B | 100% | 1432M |
| FQ3 2024 (Sep 2024) | -0.32 | -0.32 | 1.47B | 19.8% | 1470M |
| FQ2 2024 (Jun 2024) | -0.25 | -0.25 | 1.4547B | 17.17% | 1454.7M |
| FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 1.45447B | 8.49% | 1454.47M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.39189
Consensus Revenue Estimates
1.887693196B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.47426 | -- | -0.5281 | -0.4063 | 1 |
| FQ3 2027 (Sep 2027) | -0.31132 | -- | -0.34666 | -0.26671 | 1 |
| FQ2 2027 (Jun 2027) | -0.26583 | -- | -0.29601 | -0.22774 | 1 |
| FQ1 2027 (Mar 2027) | -0.29029 | -- | -0.32325 | -0.2487 | 1 |
| FQ4 2026 (Oct 2026) | -0.35545 | 507.93 | -0.38207 | -0.32262 | 0 |
| FQ3 2026 (Jul 2026) | -0.34117 | 32.58 | -0.36672 | -0.30966 | 0 |
| FQ2 2026 (Jun 2026) | -0.35885 | 35.91 | -0.38733 | -0.3277 | 0 |
| FQ1 2026 (Mar 2026) | -0.39189 | 10.69 | -0.43055 | -0.35882 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.8B | -- | 1.6B | 1.95B | 2 |
| FQ3 2027 (Sep 2027) | 1.77B | -- | 1.57B | 1.92B | 2 |
| FQ2 2027 (Jun 2027) | 1.74B | -- | 1.55B | 1.89B | 2 |
| FQ1 2027 (Mar 2027) | 1.71B | -- | 1.53B | 1.86B | 2 |
| FQ4 2026 (Oct 2026) | 2.02B | 22.46 | 1.87B | 2.13B | 4 |
| FQ3 2026 (Jul 2026) | 2.02B | 21.37 | 1.88B | 2.14B | 6 |
| FQ2 2026 (Jun 2026) | 2.02B | 16.21 | 1.88B | 2.14B | 1 |
| FQ1 2026 (Mar 2026) | 1.89B | 16.3 | 1.77B | 2.03B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.43118 | 1.45 | 1.88118 | 129.74% |
| FQ3 2025 (Sep 2025) | -0.40602 | -0.23 | 0.17602 | -76.53% |
| FQ2 2025 (Jun 2025) | -0.43739 | -0.23 | 0.20739 | -90.17% |
| FQ1 2025 (Mar 2025) | -0.35 | -0.35 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0596 | -0.0596 | 100% | |
| FQ3 2024 (Sep 2024) | -0.32 | -0.32 | 100% | |
| FQ2 2024 (Jun 2024) | -0.25 | -0.25 | 100% | |
| FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $1.79B | $1.56B | $-225.14M | -14.41% |
| FQ3 2025 (Sep 2025) | $1.8B | $1.59B | $-204.79M | -12.87% |
| FQ2 2025 (Jun 2025) | $1.79B | $1.69B | $-93.26M | -5.51% |
| FQ1 2025 (Mar 2025) | $0B | $1.58B | $1580M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.43B | $1432M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.47B | $1470M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.45B | $1454.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.45B | $1454.47M | 100% |